Real-World Data From a Molecular Tumor Board: Improved Outcomes in Breast and Gynecologic Cancers Patients With Precision Medicine We conducted a multicentric, retrospective analysis of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback